Drreddys Laboratories | RDY - Debt


Drreddys Laboratories reported INR67.73B in Debt for its fiscal quarter ending in December of 2025.





Debt Change Date
ANI Pharmaceuticals USD 620.31M 1.25M Sep/2025
Aurora Cannabis CAD 100.34M 1.29M Sep/2025
Bayer EUR 39.39B 1.31B Mar/2025
Canopy Growth CAD 259.33M 68.47M Sep/2025
Cipla INR 4.38B 231.9M Mar/2025
Corcept Therapeutics USD 6.6M 2.03M Jun/2025
Drreddys Laboratories INR 67.73B 19.09B Dec/2025
GlaxoSmithKline GBP 17.75B 396M Sep/2025
Hikma Pharmaceutical USD 1.56B 252M Jun/2025
Lonza CHF 4.71B 915M Dec/2024
Novartis USD 32.64B 1.37B Jun/2025
Pacira USD 376.72M 203.77M Sep/2025
Prestige Brands USD 1.04B 27.25M Jun/2025
Richter Gedeon HUF 21.74B 1.93B Dec/2024
Sun Pharmaceuticals INR 23.62B 2.1B Mar/2025
Supernus Pharmaceuticals USD 31.77M 531K Jun/2025
Teva Pharmaceutical Industries USD 17.07B 450M Sep/2025